These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 6969580)
21. In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus. Díez Enciso M; Mateos Lindemann M; Gutiérrez Altés A Antimicrob Agents Chemother; 1982 Dec; 22(6):1064-6. PubMed ID: 6818899 [TBL] [Abstract][Full Text] [Related]
22. In vitro activity of N-formimidoyl thienamycin (MK 0787) compared with other beta-lactamase stable cephalosporins against beta-lactamase producing Staphylococcus aureus. Ray B; Panja K; Bal M Indian J Med Res; 1984 Apr; 79():482-6. PubMed ID: 6333393 [No Abstract] [Full Text] [Related]
23. N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria. Martin DA; Sanders CV; Marier RL Antimicrob Agents Chemother; 1982 Jan; 21(1):168-9. PubMed ID: 6952818 [TBL] [Abstract][Full Text] [Related]
24. In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp. Nasu M; Maskell JP; Williams RJ; Williams JD Antimicrob Agents Chemother; 1981 Oct; 20(4):433-6. PubMed ID: 6282191 [TBL] [Abstract][Full Text] [Related]
25. [Antibacterial activity of N-formimidoyl-thienamycin in comparison with other beta-lactam antibiotics against clinical problem strains (author's transl)]. Grimm H Arzneimittelforschung; 1982; 32(6):595-7. PubMed ID: 6214262 [TBL] [Abstract][Full Text] [Related]
27. Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia. Gutiérrez-Núñez J; Harrington PT; Ramirez-Ronda CH Antimicrob Agents Chemother; 1982 Mar; 21(3):509-12. PubMed ID: 6954876 [TBL] [Abstract][Full Text] [Related]
28. Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics. Wise R; Andrews JM; Danks G Antimicrob Agents Chemother; 1983 Dec; 24(6):909-14. PubMed ID: 6607032 [TBL] [Abstract][Full Text] [Related]
29. Susceptibility of Neisseria meningitidis and Neisseria gonorrhoeae isolates to N-formimidoyl thienamycin. Dudek EJ; Stephenson JD; Bohnhoff M; Lerner SA Antimicrob Agents Chemother; 1982 Nov; 22(5):926-9. PubMed ID: 6817708 [TBL] [Abstract][Full Text] [Related]
30. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa. Corrado ML; Landesman SH; Cherubin CE Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178 [TBL] [Abstract][Full Text] [Related]
31. Sch 29482, a new oral penem: comparative in-vitro activity, beta-lactamase stability and inhibition. Barry AL; Jones RN; Wilson HW; Badal RE; Thornsberry C J Antimicrob Chemother; 1982 Feb; 9 Suppl C():97-112. PubMed ID: 6977536 [No Abstract] [Full Text] [Related]
32. Sch 29482: stability and inhibitory potency towards beta-lactamases from Gram-negative bacteria. Pechère JC; Letarte R; Guay R; Asselin C; Morin C J Antimicrob Chemother; 1982 Feb; 9 Suppl C():123-32. PubMed ID: 6977528 [No Abstract] [Full Text] [Related]